VitriVax
VitriVax is a biotech company in Boulder, United States, founded in 2017. It has raised $114.2M across 3 rounds, most recently an $87.0M Series C in November 2026.
Eliminating barriers to global vaccination
- Headquarters
- Boulder, Colorado
- Employees
- 51–200
- Founded
- 2017
- Website
- vitrivaxbio.com
- Total Funding
- $114.2M
- Last Round
- $87.0M Series CNov 2026
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.
About
It lists 51–200 employees. It has raised $114.2M in total across 3 rounds, most recently a $87.0M Series C round in Nov 2026. Investors include Adjuvant Capital, RA Capital Management and Bill & Melinda Gates Foundation.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2026
Sign up to see all 3 events
Funding: Series B through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vitrivax"><img src="https://indexed.vc/api/badge/company/vitrivax" alt="VitriVax on Indexed.vc" width="260" height="76" /></a>